Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites

Background/Objectives: New drugs are required for the treatment of liver cancers and protozoal parasite infections. Analogs of the known anticancer active and antileishmanial 2′,4′,6′-trimethoxychalcone SU086 were prepared and investigated. Methods: The chalcones were prepared according to the Clais...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandra Viperino, Michael Höpfner, Nicole Edel, Ibrahim S. Al Nasr, Waleed S. Koko, Tariq A. Khan, Imen Ben Abdelmalek, Rainer Schobert, Bernhard Biersack, Bianca Nitzsche
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/50
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587699700105216
author Alessandra Viperino
Michael Höpfner
Nicole Edel
Ibrahim S. Al Nasr
Waleed S. Koko
Tariq A. Khan
Imen Ben Abdelmalek
Rainer Schobert
Bernhard Biersack
Bianca Nitzsche
author_facet Alessandra Viperino
Michael Höpfner
Nicole Edel
Ibrahim S. Al Nasr
Waleed S. Koko
Tariq A. Khan
Imen Ben Abdelmalek
Rainer Schobert
Bernhard Biersack
Bianca Nitzsche
author_sort Alessandra Viperino
collection DOAJ
description Background/Objectives: New drugs are required for the treatment of liver cancers and protozoal parasite infections. Analogs of the known anticancer active and antileishmanial 2′,4′,6′-trimethoxychalcone SU086 were prepared and investigated. Methods: The chalcones were prepared according to the Claisen–Schmidt condensation protocol and analyzed. They were tested for activity against two liver cancer cell lines (HepG2 and HuH-7) and protozoal parasites (<i>Toxoplasma gondii</i> and <i>Leishmania major</i>). Unspecific toxicity and expression of Hsp90 and Hsp70 upon treatment were analyzed in liver cancer cells. Results: A new chalcone, 2′,4′,6′-trimethoxy-3-pentafluorosulfanylchalcone (246TMP-3SF5), with a pentafluorosulfanyl (SF<sub>5</sub>) substituent showed pronounced activities against liver cancer cells and <i>T. gondii</i> parasites which were superior to the activities of the parent chalcone SU086 in these models. In contrast, SU086 and its anthracene analog 2′,4′,6′-trimethoxy-9-anthracenylchalcone (246TMP-Anth) were most active against <i>L. major</i> promastigotes. The new SF<sub>5</sub>-substituted chalcone behaved like the known Hsp90 inhibitor 17-AAG and upregulated Hsp70 expression in liver cancer cells. Conclusions: The SF<sub>5</sub>-substituted SU086 analog has potential to become a new drug for the therapy of hepatoma and toxoplasmosis.
format Article
id doaj-art-2f77142e64784cb084a01cdeda611e01
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-2f77142e64784cb084a01cdeda611e012025-01-24T13:45:11ZengMDPI AGPharmaceuticals1424-82472025-01-011815010.3390/ph18010050Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human ParasitesAlessandra Viperino0Michael Höpfner1Nicole Edel2Ibrahim S. Al Nasr3Waleed S. Koko4Tariq A. Khan5Imen Ben Abdelmalek6Rainer Schobert7Bernhard Biersack8Bianca Nitzsche9Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, GermanyInstitute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, GermanyInstitute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Biology, College of Science, Qassim University, Qassim 51452, Saudi ArabiaDepartment of Biology, College of Science, Qassim University, Qassim 51452, Saudi ArabiaDepartment of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Ar Rass 51921, Saudi ArabiaDepartment of Biology, College of Science, Qassim University, Qassim 51452, Saudi ArabiaOrganic Chemistry Laboratory, University Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, GermanyOrganic Chemistry Laboratory, University Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, GermanyInstitute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, GermanyBackground/Objectives: New drugs are required for the treatment of liver cancers and protozoal parasite infections. Analogs of the known anticancer active and antileishmanial 2′,4′,6′-trimethoxychalcone SU086 were prepared and investigated. Methods: The chalcones were prepared according to the Claisen–Schmidt condensation protocol and analyzed. They were tested for activity against two liver cancer cell lines (HepG2 and HuH-7) and protozoal parasites (<i>Toxoplasma gondii</i> and <i>Leishmania major</i>). Unspecific toxicity and expression of Hsp90 and Hsp70 upon treatment were analyzed in liver cancer cells. Results: A new chalcone, 2′,4′,6′-trimethoxy-3-pentafluorosulfanylchalcone (246TMP-3SF5), with a pentafluorosulfanyl (SF<sub>5</sub>) substituent showed pronounced activities against liver cancer cells and <i>T. gondii</i> parasites which were superior to the activities of the parent chalcone SU086 in these models. In contrast, SU086 and its anthracene analog 2′,4′,6′-trimethoxy-9-anthracenylchalcone (246TMP-Anth) were most active against <i>L. major</i> promastigotes. The new SF<sub>5</sub>-substituted chalcone behaved like the known Hsp90 inhibitor 17-AAG and upregulated Hsp70 expression in liver cancer cells. Conclusions: The SF<sub>5</sub>-substituted SU086 analog has potential to become a new drug for the therapy of hepatoma and toxoplasmosis.https://www.mdpi.com/1424-8247/18/1/50chalconeanticancer agentantiparasitic agentliver cancerleishmaniasistoxoplasmosis
spellingShingle Alessandra Viperino
Michael Höpfner
Nicole Edel
Ibrahim S. Al Nasr
Waleed S. Koko
Tariq A. Khan
Imen Ben Abdelmalek
Rainer Schobert
Bernhard Biersack
Bianca Nitzsche
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
Pharmaceuticals
chalcone
anticancer agent
antiparasitic agent
liver cancer
leishmaniasis
toxoplasmosis
title Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
title_full Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
title_fullStr Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
title_full_unstemmed Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
title_short Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
title_sort identification of a new pentafluorosulfanyl substituted chalcone with activity against hepatoma and human parasites
topic chalcone
anticancer agent
antiparasitic agent
liver cancer
leishmaniasis
toxoplasmosis
url https://www.mdpi.com/1424-8247/18/1/50
work_keys_str_mv AT alessandraviperino identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT michaelhopfner identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT nicoleedel identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT ibrahimsalnasr identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT waleedskoko identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT tariqakhan identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT imenbenabdelmalek identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT rainerschobert identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT bernhardbiersack identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites
AT biancanitzsche identificationofanewpentafluorosulfanylsubstitutedchalconewithactivityagainsthepatomaandhumanparasites